$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Delivery systems for pharmaceutical or therapeutic actives 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/02
  • A61K-009/06
  • A61K-009/12
  • A61K-031/715
출원번호 US-0268871 (1988-11-08)
발명자 / 주소
  • Partain
  • III. Emmett M. (Bound Brook NJ) Brode
  • II. George L. (Bridgewater NJ)
출원인 / 주소
  • Union Carbide Chemicals and Plastics Company Inc. (Danbury CT 02)
인용정보 피인용 횟수 : 147  인용 특허 : 10

초록

Delivery systems containing at least one aminopolysaccharide derivative are provided for the delivery of pharmaceutical or therapeutic actives to a desired topical or mucous membrane site in a subject, and wherein upon delivery, the systems provides a biocompatible, substantive, gas permeable, film

대표청구항

A biocompatible, substantive, film-forming delivery system for the delivery of pharmaceutical or therapeutic actives to a desired topical site of a subject, said system being comprised of pharmaceutical of therapeutic actives and from about 0.1 to about 99.99 weight percent of the system of at least

이 특허에 인용된 특허 (10)

  1. Ivani Edward J. (2360 E. 74 St. Brooklyn NY 11234), Amino-polysaccharides and copolymers thereof for contact lenses and ophthalmic compositions.
  2. Jackson David S. (Princeton NJ), Chitosan-glycerol-water gel.
  3. Lang Gther (Reinheim DEX) Maresch Gerhard (Darmstadt DEX) Wendel Harald (Ober-Ramstadt DEX) Konrad Eugen (Darmstadt DEX) Lenz Hans-Rudi (Darmstadt DEX) Titze Jrgen (Gross-Bieberau DEX), Cosmetic compositions based upon N-hydroxypropyl-chitosans, new N-hyroxypropyl-chitosans, as well as processes for the p.
  4. Vanlerberghe Guy (Montjay-la-Tour FR) Sebag Henri (Paris FR), Cosmetic compositions for the skin containing a chitosan derivative.
  5. Hall Laurance D. (Vancouver CAX) Yalpani Mansur (Vancouver CAX), Derivatives of chitins, chitosans and other polysaccharides.
  6. Austin Paul R. (Wilmington DE), Dry free-flowing water-soluble complexes of chitosan.
  7. Yamahira Yoshiya (Kobe JPX) Fujioka Keiji (Amagasaki JPX) Sato Shiegeji (Ibaraki JPX) Takada Yoshihiro (Takatsuki JPX), Long-term sustained-release preparation.
  8. Koshugi Junichi (Tokyo JPX), Process for preparing porous shaped material of acylated chitin derivative.
  9. Turkov Jaroslava (CeskBrod CSX) Stamberg Jir (Prague CSX), Proteolytic, dry biopolymeric composition for treatment of wounds, and method of using same.
  10. Allan G. Graham (Seattle WA), Vision correction lens made from an aminopolysaccharide compound or an ether or ester thereof.

이 특허를 인용한 특허 (147)

  1. Toro,Carlo; Pompei,Enzo; Carlucci,Giovanni; Digiacomantonio,Marco; Salone,Fiorello, Absorbent article comprising edge barriers comprising a liquid absorbent thermoplastic composition.
  2. Singh Mohinder (Naperville IL) Vail Lisa (Bethlehem PA) Niedbala Raymond S. (Allentown PA), Aerosol spray composition for the treatment of dermal burns by cooling and anesthetizing the wound and valved container.
  3. Shelokov, Alexis P., Anterior spinal vessel protector.
  4. Mailland,Federico, Antimycotic nail varnish composition.
  5. Ferdman Ariel G. ; Pinsky Vladimir J., Apparatus and method for applying a particulate hemostatic agent to living tissue.
  6. Ducharme, Richard W.; Sugg, David E., Apparatus and methods for containing and delivering therapeutic agents.
  7. Ducharme, Richard W., Apparatus and methods for delivering therapeutic agents.
  8. Malik, Sohail, Bandage, methods of producing and using same.
  9. Soerens, Dave Allen; Malik, Sohail, Bandage, methods of producing and using same.
  10. Tipton Arthur J. (Birmingham AL) Fujita Shawn M. (Amsterdam NLX) Dunn Richard L. (Fort Collins CO), Biodegradable film dressing and method for its formation.
  11. Alan M. Polson ; Deryl D. Swanbom ; Richard L. Dunn ; Charles P. Cox ; Richard L. Norton ; Bryan K. Lowe ; Kenneth S. Peterson, Biodegradable implant precursor.
  12. Tipton Arthur J. ; Fujita Shawn M. ; Dunn Richard L., Biodegradable in situ forming film dressing.
  13. Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable polymer composition.
  14. Norton Richard L. (Fort Collins CO) Knight Stephen Michael Gregory (Fort Collins CO) Tipton Arthur J. (Birmingham AL), Biodegradable polymeric composition.
  15. Baker, Shenda; Wiesmann, William P.; Townsend, Stacy, Chitosan derivatives, compositions and related methods of use.
  16. Dean A. Oester ; Rolf Wachter DE; Jeffrey A. Gates, Chitosan formulation with azelaic acid and other actives for the treatment of acne.
  17. Ben-Shalom, Noach; Pinto, Riki, Chitosan metal complexes and method for controlling microbial growth on plants using same.
  18. Jiang Ying ; Roby Mark S., Chitosan/alginate anti-adhesion barrier.
  19. Ben-Shalom Noach,ILX ; Platt David, Compositions and method for controlling fungal disease in plants.
  20. Yeh Kuo-Chen (Westfield NJ) Sena Frank J. (Brooklyn NY) Alfano Michael C. (Franklin Lakes NJ), Compositions and method for the treatment of disease.
  21. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Compositions comprising hyaluronic acid and drugs.
  22. Falk Rudolf Edgar,CAX ; Asculai Samuel Simon,CAX, Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs.
  23. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for adm.
  24. Brode George L. (Bridgewater NJ) Doncel Gustavo F. (Norfolk VA) Gabelnick Henry L. (N. Bethesda MD) Kreeger Russell L. (Flemington NJ) Salensky George A. (White House Station NJ), Contraceptive compositions.
  25. Asculai, Samuel, Cosmetic compositions for the treatment of skin and methods thereof.
  26. Dunn, Richard L.; Yarborough, Cody L., Coupling syringe system and methods for obtaining a mixed composition.
  27. Larsen, Kristian; Sabra, Mads, Device for promotion of hemostasis and/or wound healing.
  28. Illum Lisbeth,GBX, Drug delivery compositions.
  29. Larsen, Kristian, Dry composition comprising an extrusion enhancer.
  30. Larsen, Kristian, Dry haemostatic composition.
  31. Larsen, Kristian, Dry haemostatic composition.
  32. Qian, Zhen; Osawa, A. Edward; Reich, Cary J., Dry hemostatic compositions and methods for their preparation.
  33. Qian, Zhen; Osawa, A. Edward; Reich, Cary J., Dry hemostatic compositions and methods for their preparation.
  34. Qian, Zhen; Osawa, A. Edward; Reich, Cary J.; Wallace, Donald G.; Shargill, Narinder S.; Vega, Felix, Dry hemostatic compositions and methods for their preparation.
  35. Dunn,Richard L., Emulsions for in-situ delivery systems.
  36. Illum Lisbeth (Nottingham GBX), Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving mater.
  37. Farrar John J. ; Maycock Alan L. ; Kumar Virendra ; Balogh Imre Jim, Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therew.
  38. Farrar John J. (Chester Springs PA) Maycock Alan L. (Malvern PA) Kumar Virendra (Paoli PA) Balogh Imre (Jim) (Perkasie PA), Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith.
  39. Falk Rudolf E,CAX ; Asculai Samuel S,CAX ; Klein Ehud S,ILX ; Harper David W,CAX ; Hochman David,CAX ; Purschke Don,CAX, Formulations containing hyaluronic acid.
  40. Falk Rudolf Edgar,CAX ; Asculai Samuel Simon,CAX ; Klein Ehud Shmuel,ILX ; Harper David W.,CAX ; Hochman David,CAX ; Purschke Don,CAX, Formulations containing hyaluronic acid.
  41. Falk Rudolf Edger,CAX ; Asculai Samuel Simon,CAX ; Klein Ehud Shmuel,ILX ; Harper David William,CAX ; Hochman David,CAX ; Purschke Don,CAX, Formulations containing hyaluronic acid.
  42. Wallace Donald G. ; Reich Cary J. ; Shargill Narinder S. ; Vega Felix ; Osawa A. Edward, Fragmented polymeric compositions and methods for their use.
  43. Wallace, Donald G.; Reich, Cary J.; Shargill, Narinder S.; Vega, Felix; Osawa, A. Edward, Fragmented polymeric compositions and methods for their use.
  44. Wallace, Donald G.; Reich, Cary J.; Shargill, Narinder S.; Vega, Felix; Osawa, A. Edward, Fragmented polymeric compositions and methods for their use.
  45. Wallace, Donald G.; Reich, Cary J.; Shargill, Narinder S.; Vega, Felix; Osawa, A. Edward; Qian-Wallis, Zhen, Fragmented polymeric compositions and methods for their use.
  46. Wallace, Donald G.; Reich, Cary J.; Shargill, Narinder S.; Vega, Felix; Osawa, A. Edward; Qian-Wallis, Zhen, Fragmented polymeric compositions and methods for their use.
  47. W. Roy Knowles, Hair loss prevention.
  48. Reich, Cary J.; Osawa, A. Edward; Tran, Helen, Hemoactive compositions and methods for their manufacture and use.
  49. Reich,Cary J.; Osawa,A. Edward; Tran,Helen, Hemoactive compositions and methods for their manufacture and use.
  50. Hedrich, Hans Christian; Hoefinghoff, Joris; Gorna, Katarzyna, Hemostatic compositions.
  51. McCoy, Jill; Dwyer, Joseph F.; Yang, Ziping, Hemostatic compositions.
  52. Pendharkar, Sanyog M.; Gorman, Anne J., Hemostatic compositions containing sterile thrombin.
  53. Hedrich, Hans Christian; Hoefinghoff, Joris, Hemostatic sponge.
  54. Hedrich, Hans Christian; Hoefinghoff, Joris, Hemostatic sponge.
  55. Hedrich, Hans Christian; Hoefinghoff, Joris; Rhee, Woonza M.; Osawa, Atsushi Edward, Hemostatic sponge.
  56. Hedrich, Hans Christian; Hoefinghoff, Joris; Rhee, Woonza M.; Osawa, Atsushi Edward, Hemostatic sponge.
  57. Hedrich, Hans Christian; Hoefinghoff, Joris; Rhee, Woonza M.; Osawa, Atsushi Edward, Hemostatic sponge.
  58. Hoefinghoff, Joris; Hedrich, Hans Christian, Hemostatic sponge.
  59. Garfield P. Royer, Inorganic-polymer complexes for the controlled release of compounds including medicinals.
  60. Royer, Garfield P., Inorganic-polymer complexes for the controlled release of compounds including medicinals.
  61. Royer, Garfield P., Inorganic-polymer complexes for the controlled release of compounds including medicinals.
  62. Cefali, Eugenio A.; Bova, David J., Intermediate release nicotinic acid compositions for treating hyperlipidemia.
  63. Cefali, Eugenio A., Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics.
  64. Fran.cedilla.ois Marc Karel Jozef,BEX ; Embrechts Roger Carolus Augusta,BEX ; Illum Lisbeth,GBX, Intranasal antimigraine compositions.
  65. Sung June Yoon KR; Jei Man Ryu KR; Jae Hee Jung KR; Su Jin Cho KR, Liquid suppository composition of diclofenac sodium.
  66. Johansson, Benny; Niklasson, Bo, Medical composition and uses thereof.
  67. Shelokov, Alexis P., Medical procedure involving protective pad.
  68. Polson Alan M. ; Swanbom Deryl D. ; Dunn Richard L. ; Cox Charles P. ; Norton Richard L. ; Lowe Bryan K. ; Peterson Kenneth S., Method and composition for treating a bone tissue defect.
  69. Rask Andersen,Helge; Stjernschantz,Johan, Method and compositions for local treatment of Meniere's disease, tinnitus and/or hearing loss.
  70. Odar, Johann; Nistor-Gallo, Raymond, Method for directed cell in-growth and controlled tissue regeneration in spinal surgery.
  71. Rosenberg, Thomas D.; Deffner, Kathleen, Method for supplementing the diet.
  72. Van de Casteele, Russell, Method for the delivery of a biologically active agent.
  73. Petter-Puchner, Alexander; Redl, Heinz, Method for the improvement of mesh implant biocompatibility.
  74. Petter-Puchner, Alexander; Redl, Heinz, Method for the improvement of mesh implant biocompatibility.
  75. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID.
  76. Tipton Arthur J. ; Fujita Shawn M. ; Dunn Richard L., Method of forming a biodegradable film dressing on tissue.
  77. Mailland, Federico; Legora, Michela; Ceriani, Daniela; Iob, Giuliana, Method of treating onychomycosis.
  78. Mailland, Federico; Legora, Michela; Ceriani, Daniela; Iob, Giuliana, Method of treating onychomycosis.
  79. Bova David J., Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night.
  80. Cefali, Eugenio A.; Bova, David J., Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia.
  81. Odar, Johann; Sepehrnia, Abolghassem; Schachtler, Ralph; Stemberger, Axel W., Methods for repairing and regenerating human dura mater.
  82. Bova David J., Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  83. Bova, David J, Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  84. Gruber James V. (Somerville NJ), Oxirane carboxylic acid derivatives of polyglucosamines.
  85. Dudley, Robert E.; Drouin, Dominique, Pharmaceutical composition and method for treating hypogonadism.
  86. Dudley, Robert E.; Drouin, Dominique, Pharmaceutical composition and method for treating hypogonadism.
  87. Dudley, Robert E.; Kottayil, S. George; Palatchi, Olivier, Pharmaceutical composition and method for treating hypogonadism.
  88. Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO), Polymeric compositions useful as controlled release implants.
  89. Dunn Richard L. ; Tipton Arthur J., Polymeric compositions useful as controlled release implants.
  90. Goessl, Andreas, Process for making dry and stable hemostatic compositions.
  91. Goessl, Andreas; Osawa, Atsushi Edward; Reich, Cary J., Process for making dry and stable hemostatic compositions.
  92. Goessl, Andreas; Osawa, Atsushi Edward; Reich, Cary J., Process for making dry and stable hemostatic compositions.
  93. Goessl, Andreas; Osawa, Atsushi Edward; Reich, Cary J., Process for making dry and stable hemostatic compositions.
  94. Yen Shasy-Fong ; Sou Mary, Process for preparing stabilized chitin derivative compounds.
  95. Callegaro Lanfranco,ITX ; Romeo Aurelio,ITX ; Benedetti Luca,ITX, Process for the preparation of microspheres containing biologically active components.
  96. Callegaro Lanfranco,ITX ; Romeo Aurelio,ITX ; Benedetti Luca,ITX, Process for the preparation of microspheres containing biologically active components.
  97. Rhee, Woonza M.; Reich, Cary J.; Osawa, A. Edward; Vega, Felix, Rapidly acting dry sealant and methods for use and manufacture.
  98. Rhee, Woonza M.; Reich, Cary J.; Osawa, A. Edward; Vega, Felix, Rapidly acting dry sealant and methods for use and manufacture.
  99. Garfield P. Royer, Resorbable matrices for delivery of bioactive compounds.
  100. Sampino Andrew ; Sampino Anthony, Shaving and skin conditioning lotion.
  101. Riordan Neil H., Skin treatment system.
  102. Konieczny, Michael F.; Alania, Larry; Shah, Varsha K.; McKenzie, Shannon Lea, Sustained-release fragrance delivery system.
  103. Illum Lisbeth (Nottingham GBX), Systemic drug delivery compositions comprising a polycationi substance.
  104. Ducharme, Richard W, Systems and methods for delivering therapeutic agents.
  105. Ducharme, Richard W.; Sugg, David E.; Skelton, Eugene E.; Bruggemann, Martin; Bryce, Lyndsey, Systems and methods for delivering therapeutic agents.
  106. Ducharme, Richard W.; Sugg, David E.; Skelton, Eugene; Bruggemann, Martin; Bryce, Lyndsey, Systems and methods for delivering therapeutic agents.
  107. Ducharme, Richard W.; Sugg, David E.; Skelton, Eugene; Bruggemann, Martin; Bryce, Lyndsey, Systems and methods for delivering therapeutic agents.
  108. Gustafson Stefan,CAX, Targeting of dosages of medicine and therapeutic agents.
  109. Malladi, Ramana; Miller, Jodi, Testosterone gel and method of use.
  110. Malladi, Ramana; Miller, Jodi, Testosterone gel and method of use.
  111. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  112. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  113. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  114. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  115. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  116. Malladi, Ramana; Stahlman, Jodi, Testosterone gel and method of use.
  117. Gittard, Shaun D., Therapeutic agents for delivery using a catheter and pressure source.
  118. Mailland, Federico; Legora, Michela; Ceriani, Daniela; Iob, Giuliana, Topical antifungal composition for treating onychomycosis.
  119. Miller, Bruce W., Topical composition for burn healing.
  120. Rosen Steven E. ; Brown Robert Lee, Topical compositions and methods for treating pseudofolliculitis barbae and ingrown hair.
  121. Rosen, Steven E.; Brown, Robert Lee, Topical compositions and methods for treating pseudofolliculitis barbae and ingrown hair.
  122. Rosen,Steven E., Topical compositions for veterinary uses.
  123. Rosen, Steven E.; Brown, Robert Lee, Topical compositions including deodorant compositions.
  124. Rosen Steven E. (2150 SW. 90th Ave. Unit A Ft. Lauderdale FL 33324) Brown Robert Lee (3923 Evergreen Irving TX 75061), Topical deodorant compositions.
  125. Qasem, Jaber; Farmen, Raymond H.; Phelps, Kenneth, Topical formulations of Flucytosine.
  126. Horstmann Michael (Neuwied DEX) Herrmann Fritz (Neuwied DEX), Transdermal therapeutic system exhibiting an increased active substance flow and process for the production thereof.
  127. Falk Rudolf Edgar (Toronto CAX) Asculai Samuel Simon (Toronto CAX), Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs.
  128. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Treatment of conditions and disease.
  129. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Treatment of conditions and disease.
  130. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Treatment of conditions and disease.
  131. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Treatment of conditions and disease.
  132. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Treatment of conditions and disease.
  133. Rosenthal, Gary J.; Etter, Jeffrey B.; Rodell, Timothy C.; Schauer, Wren H.; Samaniego, Adrian, Treatment of mucositis.
  134. Troha,Janice Mary; Abbas,Victoria Jean; Rosenthal,Gary Joseph; Schauer,Wren Henderson, Treatment of xerostomia.
  135. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Use of a form of hyaluronic acid and a medicinal agent for reducing rejection of organs transplantation in mammals.
  136. Odar, Johann; Nistor-Gallo, Raymond; Caliari, Laura, Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects.
  137. Falk Rudolf Edgar,CAX ; Ascuali Samuel Simon,CAX ; Turley Eva Anne,CAX, Use of hyaluronic acid and forms to prevent arterial restenosis.
  138. Falk Rudolf Edgar,CAX ; Asculai Samuel Simon,CAX ; Turley Eva Anne,CAX, Use of hyaluronic acid and forms to prevent arterial restenosis.
  139. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof.
  140. Falk Rudolf Edgar,CAX ; Asculai Samuel S.,CAX, Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents.
  141. Jean-Pierre Laugier FR; Marie-France Rude FR; Philippe Touzan FR; Fran.cedilla.ois Rigenbach FR, Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions.
  142. Laugier Jean-Pierre,FRX ; Rude Marie-France,FRX ; Touzan Philippe,FRX ; Rigenbach Francois,FRX, Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions.
  143. Dolynchuk Kenneth Nicholis,CAX ; Bowness John Michael,CAX ITX R3E OW3, Use of transglutaminase inhibitor for the treatment of scar tissue.
  144. Larsen, Kristian; Mortensen, Michael Wrang, Vacuum expanded dry composition and syringe for retaining same.
  145. Mettler Leo, Vitaminized air freshener and room deodorizer pad.
  146. Mettler Leo, Vitaminized air freshner and room deodorizer.
  147. Dannaker, Christopher J, Waterborne topical compositions for the delivery of active ingredients such as azelaic acid.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로